United Kingdom Healthcare Equipment & Supplies

EKF Diagnostics Holdings PLC (EKF)

Track

The most recent insider trading activity at EKF Diagnostics Holdings PLC occurred on December 15, 2025, when Executive Chair Julian Baines purchased 85,000 shares. No further transactions have been recorded within the last three months. Historical data shows intermittent buying and selling patterns by various directors over several years.
Ticker: EKF Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for EKF Diagnostics Holdings PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Julian Baines Executive Chair Director
Transaction date
Purchase
Price
220.42
Quantity 63,114
Value £4,578,534
Christopher Mills Non-Executive Director Executive Director
Through Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, a closely affiliated person
Transaction date
Purchase
Price
122.87
Quantity 46,182
Value £4,401,551
Christopher Mills Non-Executive Director Executive Director
Through Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, a closely affiliated person
Transaction date
Purchase
Price
88.03
Quantity 33,280
Value £2,842,379
Christopher Mills non-executive Chairman Executive Director
Through Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, a closely affiliated person
Transaction date
Purchase
Price
0.35
Quantity 1,275,000
Value £446,250
Julian Baines Non-Executive Deputy Chairman Director
Transaction date
Sale
Price
0.81
Quantity 250,000
Value £201,900
Christopher Mills Non-executive Chairman Executive Director
Transaction date
Sale
Price
0.84
Quantity 1,275,000
Value £1,071,000
Adam Reynolds Non-Executive Director Executive Director
Transaction date
Sale
Price
0.73
Quantity 500,000
Value £365,250
Christopher Mills Non-Executive Chairman Director
Transaction date
Sale
Price
0.80
Quantity 3,963,591
Value £3,170,873
Christopher Mills Non-executive Chairman Director
Transaction date
Purchase
Price
0.33
Quantity 150,000
Value £49,650
Adam Reynolds Non-executive Director Executive Director
Transaction date
Sale
Price
0.33
Quantity 400,000
Value £132,000
Mike Salter President, Americas
Transaction date
Purchase
Price
0.25
Quantity 125,000
Value £30,938
Christopher Mills Non-Executive Chairman Executive Director
Through Harwood Capital LLP, a closely affiliated person
Transaction date
Sale
Price
0.27
Quantity 491,493
Value £134,840
Adam Reynolds Non-executive Director Executive Director
Transaction date
Sale
Price
0.27
Quantity 1,250,000
Value £340,625
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-16 2025-12-15 B Purchase Julian Baines

Executive Chair

Director
63,114
220.42
£4,578,534 		63,114 220.42 £4,578,534
2024-03-25 2024-03-22 B Purchase Christopher Mills

Non-Executive Director

Through Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, a closely affiliated person Executive Director
46,182
122.87
£4,401,551 		46,182 122.87 £4,401,551
2024-01-11 2024-01-09 B Purchase Christopher Mills

Non-Executive Director

Through Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, a closely affiliated person Executive Director
33,280
88.03
£2,842,379 		33,280 88.03 £2,842,379
2022-05-03 2022-04-28 B Purchase Christopher Mills

non-executive Chairman

Through Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, a closely affiliated person Executive Director
1,275,000
0.35
£446,250 		1,275,000 0.35 £446,250
2021-11-08 2021-11-08 S Sale Julian Baines

Non-Executive Deputy Chairman

Director
250,000
0.81
£201,900 		250,000 0.81 £201,900
2021-10-05 2021-10-01 S Sale Christopher Mills

Non-executive Chairman

Executive Director
1,275,000
0.84
£1,071,000 		1,275,000 0.84 £1,071,000
2021-04-30 2021-04-30 S Sale Adam Reynolds

Non-Executive Director

Executive Director
500,000
0.73
£365,250 		500,000 0.73 £365,250
2021-04-22 2021-04-20 S Sale Christopher Mills

Non-Executive Chairman

Director
3,963,591
0.80
£3,170,873 		3,963,591 0.80 £3,170,873
2019-05-28 2019-05-24 B Purchase Christopher Mills

Non-executive Chairman

Director
150,000
0.33
£49,650 		150,000 0.33 £49,650
2019-05-28 2019-05-24 S Sale Adam Reynolds

Non-executive Director

Executive Director
400,000
0.33
£132,000 		400,000 0.33 £132,000
2018-12-19 2018-12-19 B Purchase Mike Salter

President, Americas
125,000
0.25
£30,938 		125,000 0.25 £30,938
2018-11-21 2018-11-20 S Sale Christopher Mills

Non-Executive Chairman

Through Harwood Capital LLP, a closely affiliated person Executive Director
491,493
0.27
£134,840 		491,493 0.27 £134,840
2018-11-09 2018-11-09 S Sale Adam Reynolds

Non-executive Director

Executive Director
1,250,000
0.27
£340,625 		1,250,000 0.27 £340,625
Explore more

More insider trading research around EKF Diagnostics Holdings PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in Europe